Balance Sheet
Cash Flow Statement
Cash from Financing ActivitiesCash from OperationsChange in Accured ExpensesChange in CashExchange Rate EffectFree Cash FlowGains from Investment SecuritiesGains from Sales and DivestituresNet Cash FlowNet IncomeNon-cash ItemsOther Working Capital ChangesOther financing activitiesShare-based Compensation
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Bio Green Med Solution (BGMS) Capital Expenditures (2017 - 2023)

Historic Capital Expenditures for Bio Green Med Solution (BGMS) over the last 14 years, with Q1 2023 value amounting to $6000.0.

  • Bio Green Med Solution's Capital Expenditures rose 5000.0% to $6000.0 in Q1 2023 from the same period last year, while for Dec 2023 it was $6000.0, marking a year-over-year decrease of 1428.57%. This contributed to the annual value of $6000.0 for FY2023, which is 1428.57% down from last year.
  • Latest data reveals that Bio Green Med Solution reported Capital Expenditures of $6000.0 as of Q1 2023, which was up 5000.0% from $3000.0 recorded in Q2 2022.
  • Bio Green Med Solution's 5-year Capital Expenditures high stood at $78000.0 for Q1 2021, and its period low was -$62000.0 during Q2 2021.
  • In the last 5 years, Bio Green Med Solution's Capital Expenditures had a median value of $4000.0 in 2020 and averaged $12545.5.
  • The largest annual percentage gain for Bio Green Med Solution's Capital Expenditures in the last 5 years was 185000.0% (2021), contrasted with its biggest fall of 9523.81% (2021).
  • Quarter analysis of 5 years shows Bio Green Med Solution's Capital Expenditures stood at $2000.0 in 2019, then surged by 2000.0% to $42000.0 in 2020, then tumbled by 95.24% to $2000.0 in 2021, then skyrocketed by 50.0% to $3000.0 in 2022, then surged by 100.0% to $6000.0 in 2023.
  • Its Capital Expenditures was $6000.0 in Q1 2023, compared to $3000.0 in Q2 2022 and $4000.0 in Q1 2022.